Gut Probiotics And Female Hormone Metabolism

If you have heard the word estrobolome even once, you usually come understanding to about the level that "gut health is connected to female hormones." In the clinic, the next question is always the same. "So how on earth do gut bacteria touch estrogen?" This article focuses on that "how" — the mechanism of action centered on the enzyme β-glucuronidase. By following the one step of what happens in the gut after the hormone has been processed once in the liver, you can naturally see why various changes around menopause are connected.

Our body is designed so that once it makes estrogen, it does not simply discard it but reuses a considerable portion. Estrogen circulating in the blood enters the liver and undergoes so-called phase II metabolism. At this time, the liver attaches glucuronic acid or a sulfate group to estrogen to change it into a water-soluble form, which is called conjugation.

Conjugated estrogen becomes an "inactive package" state that can no longer act directly on receptors and is excreted into the gut via bile. Up to here it is a kind of "locking process." You can understand it as binding the hormone safely and sending it out for now.

This package that has come down to the gut meets one of two fates. It is excreted as is in the stool, or gut bacteria unlock it and it is reabsorbed. What determines which way it leans is the enzyme explained next.

The core tool with which gut bacteria "intervene" in estrogen metabolism is exactly the enzyme called β-glucuronidase. When this enzyme cuts off the glucuronic acid tail that the liver attached to estrogen, the bound estrogen is released back into its active form. This is called deconjugation.

The estrogen freed through the deconjugation process is reabsorbed through the gut mucosa, returns to the liver via the portal vein, and some re-enters the systemic circulation. This flow of recycling the hormone back and forth between the liver and gut is called enterohepatic circulation. One review study summarizes that a considerable portion of estradiol goes through this recirculation pathway after being excreted in bile.

In summary, the mechanism of action is compressed into one line. The liver locks, the bacterial enzyme unlocks, and the gut reabsorbs. The estrobolome is, after all, the collective term for the bacterial community in charge of this "unlocking" step. So even when the same amount of estrogen is made, it is reported that the texture of estrogen actually remaining in the body can differ between a person with high activity of this enzyme and one with low activity.

β-glucuronidase is not the exclusive property of one or two specific bacteria. According to a study analyzing Human Microbiome Project data, the gene that makes this enzyme (the GUS gene) is distributed across various gut phyla. Bacteroidetes and Firmicutes account for most, and Verrucomicrobia and Proteobacteria make up a minority. The bacteria typically mentioned are as follows.

• Some gut bacteria such as Escherichia coli
• The Clostridium lineage (especially clusters IV, XIVa)
• The genus Bacteroides
• Some of the genus Bifidobacterium

What is interesting is that these enzymes are not structurally of one kind. They are divided into several groups according to the form of the "loop" around the active site, and this structural difference is known to affect how well and which substrate they cut. From a clinical standpoint, the reason this detail matters is clear. Rather than the simple scheme "probiotics are good," which bacteria express which enzyme and how much governs the actual amount of estrogen reabsorption. Since gut bacterial composition differs from person to person, the pattern of hormone metabolism can appear differently even with the same eating habits.

Menopause shakes this mechanism from both directions. First, the estrogen made by the ovaries itself sharply decreases. Second, it is reported that the estrogen decrease affects gut microbial diversity, so the distribution and activity of bacteria having β-glucuronidase change together. Several studies have observed a tendency for the gut microbial diversity of postmenopausal women to become lower than before menopause and for this enzyme activity to decrease.

When enzyme activity decreases, the "recycling" loop through enterohepatic circulation weakens. In other words, a double change overlaps: the estrogen being made decreases, and the circuit that draws back even what little is made becomes sluggish.

This table simplifies general research tendencies, and the pattern may differ depending on individual eating habits, medications taken, and underlying conditions. If you are curious about the overall mechanism of menopausal body changes, I recommend reading together an article organizing the causes and mechanisms of menopausal body changes.

Understanding the mechanism connects symptoms that looked separate around menopause into one strand. When estrogen reabsorption through enterohepatic circulation decreases, the systemic estrogen environment can lean lower, and this is explained as not unrelated to changes in which the vaginal mucosa thins and becomes dry, and a tendency toward recurrent vaginitis. In a commentary on the latest research dealing with the background of more frequent vaginitis after menopause, I have explained this link in more detail.

A scenario in the opposite direction is also reported. Under certain conditions, when β-glucuronidase activity becomes excessively high, estrogen reabsorption increases, and research is proceeding from the perspective of the risk of estrogen-dependent diseases. That said, I want to make clear that this is not a conclusion asserting risk but a research area examining a mechanistic possibility. High enzyme activity does not immediately cause disease, and there may be individual variation.

In clinical experience, the part patients are most confused about is this point. "If there is a lot of the enzyme, is it unconditionally bad or good?" The right answer is "balance." The understanding to date is that hormonal homeostasis can waver whether it is too weak or too strong.

Knowing the mechanism also shows where the variables of daily life intervene. A review published in 2026 summarized that long-term medications can change gut bacterial composition and affect β-glucuronidase and sulfatase activity. Drugs that broadly reduce gut bacteria, such as antibiotics, can directly shake this enzyme circuit, and some metabolic and psychiatric drugs are also reported to affect related bacterial species.

On the diet side, fiber and plant estrogens (such as soy isoflavones) are being examined in the direction of regulating the gut environment and this enzyme activity. That said, there is something that must be made clear here.

So in the clinic, we do not look at gut health alone but evaluate hormone levels, symptoms, and underlying conditions together. If needed, after confirming the overall state through menopause screening, we consult individually on whether diet and lifestyle adjustment or menopausal hormone-related care is appropriate. If you are curious about the background of why gut probiotic distribution differs from person to person, an article on how vaginal lactobacillus distribution relates to genetics may also help.

The estrobolome is not a mysterious cure-all concept but a single-step physiological phenomenon in which gut bacterial enzymes unlock the estrogen locked by the liver and make it be reabsorbed. The key called β-glucuronidase is at its center, and as the operation of this key changes around menopause, changes in the hormonal environment can appear together.

What is important is not to misunderstand this mechanism as a "guarantee of effect." Gut health is one of several factors that can affect hormonal homeostasis, and no single supplement or diet determines the result. It is far more realistic to calmly decide what to adjust based on your own symptoms and screening results.

Written by Lee Dong-hee, Director · OB-GYN specialist · See physician profile

First published January 16, 2026 · Last reviewed May 30, 2026

References: Gut microbial beta-glucuronidase a vital regulator in female estrogen metabolism, Gut Microbes (2023), Gut microbial β-glucuronidases reactivate estrogens as components of the estrobolome, Journal of Biological Chemistry (2019), Gut microbiota has the potential to improve health of menopausal women by regulating estrogen, Frontiers in Endocrinology (2025), Impact of long-term medication on estrobolome-associated β-glucuronidase and sulfatase activities, Maturitas (2026)

This article is intended to provide general health information and does not replace individual diagnosis or treatment. If you have symptoms, please consult through a medical visit.